Skip to main content
. 2024 Mar 1;36(1):47–54. doi: 10.5371/hp.2024.36.1.47

Table 1.

Patient Demographics

Total No VTE VTE P-value
No. of patients 524 458 (87.4) 66 (12.6)
Sex 0.43
Male 140 (26.7) 125 (27.3) 15 (22.7)
Female 384 (73.3) 333 (72.7) 51 (77.3)
Fracture type <0.01
Femur neck 171 (32.6) 150 (32.8) 21 (31.8)
Intertrochanter 272 (51.9) 250 (54.6) 22 (33.3)
Subtrochanter 17 (3.2) 14 (3.1) 3 (4.5)
Femur shaft 49 (9.4) 31 (6.8) 18 (27.3)
Pelvis 15 (2.9) 13 (2.8) 2 (3.0)
Comorbidities
HTN 369 (70.4) 322 (70.3) 47 (71.2) 0.88
DM 176 (33.6) 159 (34.7) 17 (25.8) 0.15
Dyslipidemia 68 (13.0) 60 (13.1) 8 (12.1) 0.83
CKD 63 (12.0) 56 (12.2) 7 (10.6) 0.71
CVA 75 (14.3) 67 (14.6) 8 (12.1) 0.59
CAD 57 (10.9) 52 (11.4) 5 (7.6) 0.36
Arrhythmia 34 (6.5) 31 (6.8) 3 (4.5) 0.49
Pulmonary disease 82 (15.6) 73 (15.9) 9 (13.6) 0.63
Pre-injury Koval score (mean) 2.58±1.93 2.56±1.91 2.71±2.06 0.55
Pre-injury Koval score <4 364 (69.5) 320 (69.9) 44 (66.7) 0.58
Time from injury to admission 0.67
<24 hr 388 (74.0) 343 (74.9) 45 (68.2)
≥24, <72 hr 69 (13.2) 59 (12.9) 10 (15.2)
≥72 hr 67 (12.8) 56 (12.2) 11 (16.7)
Anticoagulant 161 (30.7) 149 (32.5) 12 (18.2) 0.02
Cancer history 57 (10.9) 48 (10.5) 9 (13.6) 0.44
Smoking 37 (7.1) 35 (7.6) 2 (3.0) 0.17
Elevated INR 29 (5.5) 26 (5.7) 3 (4.5) 0.71
Age (yr) 78.54±10.71 78.52±10.76 78.67±10.42 0.92
Height (m) 1.58±0.07 1.58±0.71 1.57±0.09 0.49
Weight (kg) 56.87±9.61 56.71±9.54 57.92±10.11 0.34
BMI (kg/m2) 22.86±3.33 22.79±3.33 24.38±2.94 0.03
≥25 112 (21.4) 89 (19.4) 23 (34.8) <0.01
D-dimer (mg/L) 16.10±12.83 16.70±12.95 12.25±11.12 <0.01

Values are presented as number (%) or mean±standard deviation.

VTE: venous thromboembolism, HTN: hypertension, DM: diabetes mellitus, CKD: chronic kidney disease, CVA: cerebrovascular accident, CAD: coronary artery disease, INR: international normalized ratio, BMI: body mass index.